DOTA (chelator) (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "DOTA (chelator)" in English language version.

refsWebsite

Global rank English rank

7doi.org

2^nd place

5nih.gov

4^th place

1ama-assn.org

3,257^th place

3,398^th place

1clinicaltrials.gov

5,225^th place

4,062^nd place

ama-assn.org

"Statement On A Nonproprietary Name Adopted By The USAN Council: Yttrium Y90 clivatuzumab tetraxetan" (PDF). American Medical Association.

clinicaltrials.gov

A Clinical Study of Gadoteric Acid in Non-Coronary Magnetic Resonance (MR) Angiography, 25 November 2008

doi.org

Viola-Villegas, Nerissa; Doyle, Robert P (2009). "The coordination chemistry of 1,4,7,10-tetraazacyclododecane-N,N′,N",N′"-tetraacetic acid (H4DOTA): Structural overview and analyses on structure–stability relationships". Coordination Chemistry Reviews. 253 (13–14): 1906. doi:10.1016/j.ccr.2009.03.013.
Stetter, Hermann; Wolfram Frank (1976). "Complex Formation with Tetraazacycloalkane-N,N',N'',N''';-tetraacetic Acids as a Function of Ring Size". Angewandte Chemie International Edition in English. 15 (11): 686. doi:10.1002/anie.197606861.
Moi, Min K.; Claude F. Meares; Sally J. DeNardo (1988). "The peptide way to macrocyclic bifunctional chelating agents: synthesis of 2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid and study of its yttrium(III) complex". Journal of the American Chemical Society. 110 (18): 6266–6267. doi:10.1021/ja00226a063. PMID 22148823.
Volkert, Wynn A.; Timothy J. Hoffman (1999). "Therapeutic Radiopharmaceuticals". Chemical Reviews. 99 (9): 2269–2292. doi:10.1021/cr9804386. PMID 11749482.
Breeman, W. A. P.; De Blois, E.; Sze Chan, H.; Konijnenberg, M.; Kwekkeboom, D. J.; Krenning, E. P. (2011). "68Ga-labeled DOTA-Peptides and 68Ga-labeled Radiopharmaceuticals for Positron Emission Tomography: Current Status of Research, Clinical Applications, and Future Perspectives". Seminars in Nuclear Medicine. 41 (4): 314–321. doi:10.1053/j.semnuclmed.2011.02.001. PMID 21624565.
Domingo, R. J.; Reilly, R. M. (2000). "Pre-targeted radioimmunotherapy of human colon cancer xenografts in athymic mice using streptavidin-CC49 monoclonal antibody and 90Y-DOTA-biotin". Nuclear Medicine Communications. 21 (1): 89–96. doi:10.1097/00006231-200001000-00015. PMID 10717908.
Knör, S; Modlinger, A; Poethko, T; Schottelius, M; Wester, HJ; Kessler, H (2007). "Synthesis of novel 1,4,7,10-tetraazacyclodecane-1,4,7,10-tetraacetic acid (DOTA) derivatives for chemoselective attachment to unprotected polyfunctionalized compounds". Chemistry: A European Journal. 13 (21): 6082–90. doi:10.1002/chem.200700231. PMID 17503419.

nih.gov

pubmed.ncbi.nlm.nih.gov

Moi, Min K.; Claude F. Meares; Sally J. DeNardo (1988). "The peptide way to macrocyclic bifunctional chelating agents: synthesis of 2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid and study of its yttrium(III) complex". Journal of the American Chemical Society. 110 (18): 6266–6267. doi:10.1021/ja00226a063. PMID 22148823.
Volkert, Wynn A.; Timothy J. Hoffman (1999). "Therapeutic Radiopharmaceuticals". Chemical Reviews. 99 (9): 2269–2292. doi:10.1021/cr9804386. PMID 11749482.
Breeman, W. A. P.; De Blois, E.; Sze Chan, H.; Konijnenberg, M.; Kwekkeboom, D. J.; Krenning, E. P. (2011). "68Ga-labeled DOTA-Peptides and 68Ga-labeled Radiopharmaceuticals for Positron Emission Tomography: Current Status of Research, Clinical Applications, and Future Perspectives". Seminars in Nuclear Medicine. 41 (4): 314–321. doi:10.1053/j.semnuclmed.2011.02.001. PMID 21624565.
Domingo, R. J.; Reilly, R. M. (2000). "Pre-targeted radioimmunotherapy of human colon cancer xenografts in athymic mice using streptavidin-CC49 monoclonal antibody and 90Y-DOTA-biotin". Nuclear Medicine Communications. 21 (1): 89–96. doi:10.1097/00006231-200001000-00015. PMID 10717908.
Knör, S; Modlinger, A; Poethko, T; Schottelius, M; Wester, HJ; Kessler, H (2007). "Synthesis of novel 1,4,7,10-tetraazacyclodecane-1,4,7,10-tetraacetic acid (DOTA) derivatives for chemoselective attachment to unprotected polyfunctionalized compounds". Chemistry: A European Journal. 13 (21): 6082–90. doi:10.1002/chem.200700231. PMID 17503419.